Drug Treatment of Hyperuricemia to Prevent Cardiovascular Outcomes: Are We There Yet?

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.12, Iss.1, 2012-02, pp. : 1-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hyperuricemia and Adverse Outcomes in Cardiovascular Disease: Potential for Therapeutic Intervention

By Gavin A.R. Struthers A.D.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 5, 2003-01 ,pp. : 309-314

Adis International

Access to resources Recommend Favorite

Drug discovery for hyperuricemia

By Anzai Naohiko Endou Hitoshi

Expert Opinion on Drug Discovery, Vol. 2, Iss. 9, 2007-09 ,pp. : 1251-1261

Informa Healthcare

Access to resources Recommend Favorite

Drug Treatment of Obesity in Cardiovascular Disease

By Charakida Marietta Finer Nicholas

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 2, 2012-04 ,pp. : 93-104

Adis International

Access to resources Recommend Favorite

Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk

Current Pharmaceutical Design, Vol. 19, Iss. 13, 2013-04 ,pp. : 2432-2438

Bentham Science Publishers

Access to resources Recommend Favorite

Virtual Screening: Are We There Yet?

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 10, 2006-10 ,pp. : 1159-1167

Bentham Science Publishers

Access to resources Recommend Favorite